Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy

In a recent study posted to the medRxiv* pre-print server, a team of researchers comprehensively investigated a public-facing office in England where a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak occurred during August-September 2021 to identify workplace and worker-related risk factors.

Study: An outbreak of SARS-CoV-2 in a public-facing office in England, 2021. Image Credit: Halfpoint/ShutterstockStudy: An outbreak of SARS-CoV-2 in a public-facing office in England, 2021. Image Credit: Halfpoint/Shutterstock

The public office had implemented site-specific control measures to contain the spread of coronavirus disease 2019 (COVID-19). They had imparted COVID-19 training to workers, deployed commercial hand sanitizers, arranged for single occupancy desks with two-meter spacing, and placed plastic dividers between workers and the public.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

About the study

In the present study, the researchers conducted a comprehensive investigation of a three-story public sector facility (outbreak site) where a SARS-CoV-2 outbreak had occurred between August and September 2021. Later, a ‘circuit break’ closure was implemented at the outbreak site to stop transmission within the workplace.

The study team, COVID-19 Outbreak study Investigation to Understand Transmission (COVID-OUT), performed extensive investigations including surface sampling, environmental assessment, molecular and serological testing at the outbreak site between September and October 2021.

Of the 40 facility workers, 12 consented to participate in the COVID-OUT study. The participants completed online questionnaires, two rounds of SARS-CoV-2 antibody testing, and three rounds of the self-administered nose and throat swabs for quantitative reverse transcription-polymerase chain reaction (qRT-PCR) testing. 

To assess the ventilation conditions of the site, CO2 measurements were used as a proxy; CO2 concentrations were determined by spot measurements when the facility reopened with continuous measurements logged over the subsequent two-week period in selected locations. 

The researchers also performed two rounds of surface sampling - the first during the circuit break and the second round approximately two weeks after the site re-opened.

Findings

The results confirmed that despite strictly adhering to governmental COVID-19 control guidance and high vaccination coverage, a SARS-CoV-2 outbreak affected 55% of the workforce at the outbreak site, a three-story public sector facility. The overall SARS-CoV-2 attack rate was 55%, and it impacted 75% of cleaning staff, 47% of office staff, and 67% of security staff.

In total, 60 surfaces were tested at the outbreak site in the first round of sampling, of which 10 (16.7%) were confirmed positives, and one (1.7%) was a suspected positive. The surface sampling results highlighted that the security office was a site of enhanced contamination. Six of nine (66.7%) samples from this location tested positive, including three in the 32.0-34.9 Ct bracket. Therefore, before reopening, the site was extensively cleaned. Moreover, routine cleaning procedures were updated, especially for the confined security office area.

Although largely by natural means, the ventilation facilities at the site conformed with current guidance, including the security office. Therefore, CO2 levels did not exceed 1200 ppm and typically were <700ppm. 

Of the 12 study participants, 41.7% (5/12) were SARS-CoV-2-positive during the outbreak period, as confirmed by COVID-OUT serological testing. All the participants, including the five SARS-CoV-2-positive cases, were immunized with two doses of COVID-19 vaccines. Additionally, SARS-CoV-2-positive individuals were symptomatic, displaying one of the following symptoms: fever, dry cough, productive cough, shortness of breath, and loss of taste or smell. 

Two-thirds of participants reported using face masks both at work and outside of work, with a higher proportion of non-cases using face masks nearly all the time. Two cases and two non-cases reported having direct physical contact with co-workers and the public. 

Conclusions 

Overall, the study findings highlighted the need for continually evolving, site-specific risk assessments that quickly adapt to changes in local community infection rates while recognizing heterogeneity within a workplace.

When this outbreak occurred, government guidelines did not mandate social distancing and mask usage. Over 75% of local residents had received two doses of COVID-19 vaccines before the outbreak. However, two weeks before the outbreak, government guidance was amended, and hence fully vaccinated people were not required to self-isolate even if they came in close contact with someone having COVID-19. Moreover, ventilation on site was adequate, predominately natural, with some forced mechanical general ventilation.

Despite being fully vaccinated, individuals contracted SARS-CoV-2 infections during this outbreak, thus reinforcing the significance of a multi-layered SARS-CoV-2 transmission mitigation strategy, in addition to vaccination. These strategies include appropriate transmission control measures, such as face masks, adequate ventilation, and social distancing to prevent severe COVID-19 illness and death.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Neha Mathur

Written by

Neha Mathur

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mathur, Neha. (2022, February 04). Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20220204/Investigation-of-SARS-CoV-2-outbreak-in-UK-office-highlights-the-need-for-a-site-specific-COVID-19-prevention-strategy.aspx.

  • MLA

    Mathur, Neha. "Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20220204/Investigation-of-SARS-CoV-2-outbreak-in-UK-office-highlights-the-need-for-a-site-specific-COVID-19-prevention-strategy.aspx>.

  • Chicago

    Mathur, Neha. "Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy". News-Medical. https://www.news-medical.net/news/20220204/Investigation-of-SARS-CoV-2-outbreak-in-UK-office-highlights-the-need-for-a-site-specific-COVID-19-prevention-strategy.aspx. (accessed November 24, 2024).

  • Harvard

    Mathur, Neha. 2022. Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20220204/Investigation-of-SARS-CoV-2-outbreak-in-UK-office-highlights-the-need-for-a-site-specific-COVID-19-prevention-strategy.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients